Recombinant fibronectin with anti-wrinkle repairing function and preparation method and application of recombinant fibronectin

A fibronectin and functional technology, applied in the field of its preparation and recombinant fibronectin, can solve the problems of difficulty in removing His-tag, no recombinant fibronectin, insufficient specificity, etc., and achieve a wide salt ion concentration Tolerance range, excellent temperature stability range, high purity effect

Active Publication Date: 2020-08-18
江苏费森尤斯医药用品有限公司 +2
5 Cites 0 Cited by

AI-Extracted Technical Summary

Problems solved by technology

[0008] Purification using metal affinity packing usually requires the introduction of 6 histidine tags on the target protein, that is, the His-tag tag, which has a minimum of 6 amino acid residues, good water solubility, and usually does not affect the structure and function of the protein , In terms of pharmaceuticals or other applications where His6-tag has adverse effects, it is necessary to remove the His-tag tag, but removing the His-tag is a huge difficulty. The conventional solution is to introduce a gap between the His6-tag and the target protein The enzymatic cleavage site of protease, the fusion protein after rough purification can be processed by specific protease, which can cut off the label, usually using thrombin (Thrombin), activated coagulation factor ten (FactorXa), tobacco mosaic virus protease TEV, etc. to cut, but These enzymes often have insufficient specificity, and will cut or even leave redundant amino acid residues in the target protein sequence; in recent years, it has ...
View more

Method used

The advantage of this preparation method is: (1) His-SUMO tag increases the solubility of recombinant fibronectin rFN and improves expression level; High efficiency recovery (up to 90% or more); (3) ULP1 protease with a specific cleavage efficiency greater than 99% can effe...
View more

Abstract

The invention belongs to the technical field of biology. The invention relates to a recombinant fibronectin with anti-wrinkle repairing functions. The recombinant fibronectin comprises at least one RGD structural domain capable of being combined with a cytointegrin receptor, and at least one sodium ion channel binding peptide fragment capable of acting on a sodium ion channel, the RGD structural domain and the sodium ion channel binding peptide fragment are connected through a polypeptide connecting fragment containing 0-300 amino acid residues, the capability of combining a sodium ion channeland an integrin receptor is realized, the effects of promoting skin repair and metabolic renewal and enhancing freckle fading and wrinkle reducing are achieved, and the process for the preparation thereof, high-density fermentation, super-tolerant metal affinity chromatography purification, specific protease label excision and ion column refining purification methods are adopted. The preparationmethod utilizes high-density fermentation, super-tolerant metal affinity chromatography purification, specific protease excision label and ion column refining purification method. The obtained recombinant fibronectin rFN does not contain a purification label, is high in purity, high in specific activity, simple and efficient in preparation process, low in cost and suitable for large-scale production, and further relates to an application of the recombinant fibronectin rFN in in-vitro adherent cell culture, skin injury repair, wrinkle removal and spot fading.

Application Domain

Cosmetic preparationsConnective tissue peptides +3

Technology Topic

Affinity chromatographyIonic Channels +19

Image

  • Recombinant fibronectin with anti-wrinkle repairing function and preparation method and application of recombinant fibronectin
  • Recombinant fibronectin with anti-wrinkle repairing function and preparation method and application of recombinant fibronectin
  • Recombinant fibronectin with anti-wrinkle repairing function and preparation method and application of recombinant fibronectin

Examples

  • Experimental program(4)

Example Embodiment

[0050] Example 1: Recombinant fibronectin with anti-wrinkle repair function
[0051] The invention relates to a recombinant fibronectin with anti-wrinkle repair function, the recombinant fibronectin sequence includes at least one RGD domain that can bind to cell integrin receptors, at least one section that can act on sodium ion channels and bind to sodium ion channels A peptide segment, the RGD structural domain and the sodium ion channel binding peptide segment are connected by a polypeptide linking segment comprising 0-300 amino acid residues.
[0052] Based on the function of natural conus peptide, its Mu-CnIIIC fragment is selected as the sodium ion channel binding peptide, and the amino acid sequence of the Mu-CnIIIC fragment is QGCC XXXXX css XX C B DH Z RCCGRR, X in the amino acid sequence of the Mu-CnIIIC fragment is any one of 20 amino acid residues, namely glycine, alanine, valine, leucine, isoleucine, phenylalanine , Proline, Tryptophan, Tyrosine, Serine, Cysteine, Methionine, Asparagine, Glutamine, Threonine, Aspartic Acid, Glutamic Acid, Lysine, Arginine , any one of histidine, B is any one of the basic residue lysine Lys, arginine Arg residue, Z is the small side chain residue glycine Gly, alanine Ala, serine Ser any of the.
[0053] The amino acid sequence of the Mu-CnIIIC fragment is shown in SEQ ID NO.3, and the coding nucleic acid sequence is shown in SEQ ID NO.4.
[0054] Based on the function of the natural fibronectin domain, the FnIII-10 domain of the natural fibronectin is selected as the RGD domain. The amino acid sequence of the FnIII-10 domain is shown in SEQ ID NO.1, encoding nucleic acid The sequence is shown in SEQ ID NO.2. The amino acid sequence of SEQ ID NO.1 contains three consecutive amino acid residue sequences of Arg-Gly-Asp, which are used for binding to integrin receptors of specific types of cells.
[0055] The structural domains FnIII-8 and FnIII-9 from natural fibronectin were selected as polypeptide linking fragments, and the FnIII-10 structural domain and the Mu-CnIIIC fragment were connected to obtain the amino acid sequence of recombinant fibronectin as shown in SEQ ID NO.9. The coding nucleotide sequence is shown in SEQ ID NO.10.

Example Embodiment

[0056] Example 2: Preparation method of recombinant fibronectin with anti-wrinkle repair function
[0057] 1. Preparation method of recombinant fibronectin with anti-wrinkle repair function
[0058] Include the following steps:
[0059] (1) Vector construction
[0060] like Figure 2A Indicated by the arrow 1, the FnIII-8, FnIII-9, FnIII-10 domains of natural fibronectin are intercepted, and the Mu-CnIIIC fragment of the natural conus peptide is intercepted, and the FnIII The -10 domain is connected to the Mu-CnIIIC fragment, and the FnIII-8, FnIII-9, FnIII-10 domain and Mu-CnIIIC fragment are seamlessly spliced ​​by whole gene optimization and synthesis to obtain the coding DNA of recombinant fibronectin rFN.
[0061] like Figure 2A Indicated by the arrow 2, the DNA encoding the recombinant fibronectin rFN was inserted into the appropriate reading frame position of the pSmart-I vector. The pSmart-I vector was purchased from Changzhou Tiandi Renhe Biotechnology Co., Ltd. to obtain the fusion protein His - The recombinant expression vector pSmart-I-rFN plasmid of SUMO-rFN.
[0062] The framework map of the pSmart-I vector and the frame map of the recombinant expression vector pSmart-I-rFN plasmid are shown in Figure 1A and Figure 1B , wherein the original pSmart-I vector contains the coding frame of His-SUMO, and the coding DNA sequence of recombinant fibronectin rFN is inserted into the coding frame of His-SUMO, and a protein encoding a fusion of His-SUMO and recombinant fibronectin is obtained. rFN expression plasmid pSmart-I-rFN.
[0063] The amino acid sequence of the fusion protein His-SUMO-rFN is shown in SEQ ID NO.11, the nucleic acid sequence of the pSmart-I vector is shown in SEQ ID NO.12, and the nucleic acid sequence of the recombinant expression vector pSmart-I-rFN plasmid is shown in SEQ ID Shown in NO.13.
[0064] (2) Shake flask expression
[0065] like Figure 2A Indicated by the arrow 3, the recombinant expression vector pSmart-I-rFN plasmid was transferred into the Escherichia coli expression strain, and the shake flask was identified to obtain a positive genetically engineered bacterium BL21(DE3)/pSmart-I-rFN.
[0066] Specifically: transfer the recombinant expression vector pSmart-I-rFN plasmid into Escherichia coli BL21(DE3), obtain positive genetically engineered bacteria BL21(DE3)/pSmart-I-rFN, pick positive transformants and inoculate them into 600ml LB medium Cultivate until the OD600 reaches 0.6, add isopropylthiogalactopyranoside (IPTG) at a final concentration of 1 mmol/L to induce fermentation, IPTG is the inducer, induce at 37°C for 4 hours, or at 22°C for 6 hours, 4 hours Centrifuge at 7000r/min for 10min to collect the cells, add 30mL of TBS (Tris-HCl 25mM, NaCl 150mM, pH7.4) to resuspend the cells, ultrasonically break the cell suspension until the solution is clear, centrifuge at 12000r/min for 10min, and collect the whole cells The lysate and supernatant were analyzed by SDS-PAGE to detect the expression of fusion protein His-SUMO-rFN.
[0067] Among them, the recombinant expression vector pSmart-I-rFN itself has kanamycin resistance and a T7 promoter. After being transferred into the E. coli BL21 (DE3) expression strain, the T7 RNA polymerase contained in the strain can initiate fusion Protein gene transcription, under the induction condition of isopropylthiogalactopyranoside (IPTG), can utilize the protein translation system of Escherichia coli itself, can express fusion protein His-SUMO-rFN, this fusion protein His-SUMO-rFN carries His-tag tags can be used for metal affinity purification; with a SUMO tag protein for specific cleavage by proteases, and with a functional fragment rFN from natural fibronectin, after screening, a small amount of expression in shake flasks can The soluble portion of the fusion protein His-SUMO-rFN reaches 40mg/ml, and the soluble portion of the fusion protein His-SUMO-rFN reaches more than 90%. After affinity purification by nickel column, the His-SUMO tag and rFN fragment can be efficiently cut with ULP1 protease.
[0068] (3) Scale fermentation
[0069] The positive genetically engineered bacterium BL21(DE3)/pSmart-I-rFN obtained in the step (2) is inoculated into 37 ℃ of cultivating in 600mlLB substratum overnight as seed liquid, 600ml seed liquid is inoculated in 50L fermentation medium, at 37 Fermentation was carried out by constant temperature culture at ℃ temperature. After 4 hours of fermentation culture, the fermentation feed was added at a rate of 800ml/h. In the 8th hour, the OD600 of the fermentation broth reached more than 30. At this time, 15g of inducer isopropylthio was added to the fermentation broth. Induced expression of galactoside (IPTG), after adding the inducer, continue to add fermentation feed to the fermentation broth at a rate of 1000ml/h, the 14th hour (6 hours after induction) the OD600 of the fermentation broth reaches more than 50, and the fermentation is terminated , centrifuged to obtain fermentation sludge.
[0070] And after adding the inducer IPTG for induction, it is necessary to take samples every hour and use SDS-PAGE analysis to detect the expression of the fusion protein His-SUMO-rFN, the results are shown in image 3 shown.
[0071]The formula of the fermentation medium is: 2.5g/L ammonium sulfate, 6.25g/L potassium dihydrogen phosphate, 5g/L yeast extract powder and 10g/L peptone, the formula of the fermentation feed is: 400g/L glycerin, 200g/L L peptone.
[0072] (4) Super nickel-resistant affinity purification
[0073] like Figure 2A The purification process flow diagram of the recombinant fibronectin rFN indicated by the arrow 4, such as Figure 2B As indicated by the arrow in 4.1, the fermentation sludge obtained in step (3) was homogeneously crushed, treated by centrifugal filtration, and subjected to third-generation ultra-nickel-resistant affinity purification on a chromatographic column to obtain the eluted fusion protein His- SUMO-rFN.
[0074] Specifically: 6000g of fermented bacteria sludge is collected by centrifugal force, the supernatant is discarded, and the remaining bacteria sludge is suspended and dispersed in TBS buffer solution pre-cooled by ice water, and the bacteria are homogeneously broken under 60MPa pressure and high pressure, and then at a low temperature of 4, 10000g Centrifugal high-speed centrifugation to remove bacterial fragments, 0.22um membrane filtration to further process the supernatant of the lysate sample before loading into the column;
[0075] The supernatant was applied to a chromatographic column for super-nickel-resistant affinity purification. The packing type of the nickel column was Smart-Ni 6FF, which was purchased from Changzhou Tiandi Renhe, and the radial flow rate of the sample was 200cm/hour. Finally, the following three The eluent was eluted in the order of imidazole concentration from low to high, and the eluted fusion protein His-SUMO-rFN was obtained, and the SDS-PAGE electrophoresis test of the eluted sample His-SUMO-rFN was carried out. The test results are shown in Figure 5 shown. The eluted fractions with purity reaching the standard were combined for the next step of purification.
[0076] Among them: the balance solution is TBS buffer solution (Tris-HCl 25mM, NaCl 150mM, pH7.4);
[0077] Washing solution: TBS buffer containing 5mM imidazole (Tris-HCl 25mM, NaCl 150mM, imidazole 5mMpH7.4);
[0078] Eluent: TBS buffer containing different concentrations of imidazole
[0079] The first eluent: TBS buffer containing imidazole concentration of 20mM (Tris-HCl 25mM, NaCl 150mM, imidazole 20mM, pH 7.4);
[0080] The second eluent: TBS buffer (Tris-HCl 25mM, NaCl 150mM, imidazole 50mM, pH 7.4) containing imidazole concentration of 50mM;
[0081] The third eluent: TBS buffer containing 250 mM imidazole (Tris-HCl 25 mM, NaCl 150 mM, imidazole 250 mM, pH 7.4).
[0082] (5) Enzyme cutting and hanging back to remove tags, ion column purification
[0083] Enzyme cut back to remove tags: eg Figure 2B As indicated by the arrow 4.2 in the figure, take the fusion protein His-SUMO-rFN obtained in step (4) after being eluted from a nickel column, and add ULP1 protease to cut off the His-SUMO tag. Figure 4 , the molar ratio of fusion protein His-SUMO-rFN to ULP1 protease is 1000:1, ULP1 protease was purchased from Zhenjiang Ruihua Biotechnology Co., Ltd., its amino acid sequence is shown in SEQ ID NO.7, and its coding nucleic acid sequence is shown in SEQ ID NO .8, digested at 4°C for 2 hours to obtain the digested recombinant fibronectin rFN buffer.
[0084] Dilute the recombinant fibronectin rFN buffer with TBS buffer that does not contain imidazole, hang it back on the ultra-resistant nickel column, wash and collect the recombinant fibronectin rFN that is partially retained in the chromatography column with 10 times the column volume of TBS buffer, Combine the washout and washout.
[0085] Ion column refining and purification: such as Figure 2B As indicated by the arrow 4.3, the above-mentioned combined permeate and flushing solution are switched to low-salt phosphate buffer (PB) buffer in the hollow fiber system for ion exchange packing purification. The packing type is cation exchange packing CM 6FF Beads , that is, carboxymethyl high-flow rate agarose was purchased from Changzhou Tiandi Renhe, and finally eluted with a salt gradient elution solution containing 100mM/200mM/500mM NaCl. All eluted samples were tested by SDS-PAGE electrophoresis. The test results are shown in Image 6 shown.
[0086] PB buffer: sodium dihydrogen phosphate (NaH 2 PQ 4 ) 25mM, pH 6.5;
[0087] The eluent is PBS buffer containing different concentrations of sodium chloride;
[0088] The first eluent: PBS buffer containing 100mM sodium chloride (25mM NaH 2 PQ 4 , 100mM NaCl, pH 6.5);
[0089] The second eluent: PBS buffer containing 200mM sodium chloride (25mM NaH 2 PQ 4 , 200mM NaCl, pH 6.5);
[0090] The third eluent: PBS buffer containing 500mM sodium chloride (25mM NaH 2 PQ 4 , 500mM NaCl, pH 6.5).
[0091] In this application, the N-terminus of the SUMO part of the purification tag His-SUMO contains a histidine tag for purification. The histidine tag contains greater than or equal to 6 His amino acid residues, and the amino acid sequence of the purification tag His-SUMO As shown in SEQ ID NO.5, the coding nucleic acid sequence is shown in SEQ ID NO.6.
[0092] 2. Results
[0093] 1. Time-series electrophoresis test of the expression level of His-SUMO-rFN large-scale fermentation
[0094] like image 3 It is the time-series electrophoresis diagram of the fusion protein His-SUMO-rFN large-scale fermentation expression, in which the first well is the sample before induction, and the second, third, fourth, fifth, and sixth wells are the induction time of 2h, 3h, 4h, and 5h, respectively. , 6h sample, M is the pre-stained molecular weight protein marker.
[0095] according to image 3 As shown, in the large-scale fermentation process, the background expression before induction was controlled at a very low level, and there was no obvious fusion protein His-SUMO-rFN band in the sample before induction, and the molecular weight was about 54kDa. After adding the inducer IPTG After 2 hours, the proportion of the fusion protein His-SUMO-rFN to the total bacterial protein content increased, and reached a plateau after 5 hours, with a molecular weight of about 54kDa. After 6 hours of induction, it can be placed in the tank and the fermentation broth harvested.
[0096] According to the amount of sample loaded (1ul fermentation broth sample amount per well) and the gray scale of the stained bands, the expression level per unit volume of fermentation broth can reach more than 8g/L 6 hours after induction. The concentration can continue to rise, increasing the cell density by 2-3 times, and the OD600 of the final fermentation product exceeds 100. Correspondingly, the expression amount per unit volume of fermentation broth exceeds 10g/L.
[0097] 2. Electrophoresis test of His-SUMO-rFN digestion efficiency
[0098] like Figure 4 As shown in the electrophoresis diagram of the digestion efficiency of His-SUMO-rFN, the first well is the fusion protein His-SUMO-rFN before digestion, the second well is the sample digested for 1 hour, and the third hole is the sample digested for 2 hours. Sample, M is the pre-stained molecular weight protein marker.
[0099] The results show that ULP1 protease can efficiently cut the His-SUMO-rFN fusion protein (molecular weight is about 54kDa), and the digestion efficiency is greater than 95% in 1 hour and greater than 99% in 2 hours. The two fragments His-SUMO fragment (approximate molecular weight about 20kDa) and rFN fragment (apparent molecular weight about 34kDa) after enzyme digestion were of correct size.
[0100] 3. Purification test of His-SUMO-rFN metal affinity filler (Smart Ni)
[0101] Figure 5 The electrophoresis test chart of the samples in each stage of the metal affinity filler purification process for the fusion protein His-SUMO-rFN, the first hole is the lysate supernatant before loading the fusion protein, the second hole is the flow-through, The 3rd, 4th, and 5th wells were used respectively with the first eluent (TBS buffer containing imidazole concentration of 20mM), the second eluate containing imidazole concentration (TBS buffer containing imidazole concentration of 50mM), the second eluate The eluted fractions obtained by elution with three eluents (TBS buffer containing imidazole concentration of 20mM), the sixth well is the residual fusion protein His-SUMO-rFN on the filler, and M is the pre-stained molecular weight protein Marker.
[0102] The results of electrophoresis show that the fusion protein His-SUMO-rFN can be efficiently captured by the filler Smart-Ni 6FF, and the recovery rate of one-step affinity chromatography can reach more than 90%. In dehydration. The SDS-PAGE electrophoresis was analyzed using grayscale scanning analysis software, and the purity of the harvested fusion protein His-SUMO-rFN was greater than 95%.
[0103] 4. Purification test of recombinant fibronectin rFN cation exchange medium (CM)
[0104] Image 6 Cation exchange medium (CM) for recombinant fibronectin rFN, that is, the electrophoresis test chart of samples at each stage of the purification process. The first hole in the figure is the recombinant fibronectin rFN after Smart Ni back-hanging to remove the label, and the second hole The first eluent (PBS buffer containing 100mM sodium chloride) and the second eluent (PBS buffer containing 200mM sodium chloride) were used for the 3rd, 4th, and 5th wells respectively. 1. The elution fraction obtained by eluting with the third eluent (PBS buffer solution containing 500 mM sodium chloride), the sixth well is the recombinant fibronectin rFN remaining on the filler, and M is the pre-stained molecular weight protein Marker.
[0105] The results showed that recombinant fibronectin rFN could be efficiently adsorbed by cation exchange packing CM, and there was a small amount of recombinant fibronectin rFN in the permeate, accounting for less than 5%.
[0106] After high-salt elution, recombinant fibronectin rFN is mainly located in the eluent containing 200mM and 500mM NaCl concentration, and the residual ratio on the column is less than 5%, and the recombinant fibronectin rFN recovered by high-salt elution has no obvious Miscellaneous bands can be seen, and the electrophoretic purity is greater than 99%.
[0107] Purified by His-SUMO-rFN metal affinity filler and recombinant fibronectin rFN cation exchange filler, the total recovery rate of the obtained recombinant fibronectin rFN is greater than 90%, the His-SUMO tag is completely removed, and the recombinant fibronectin rFN Toxin levels are less than 0.001 EU/ug.

Example Embodiment

[0108] Example 3: Stability test of recombinant fibronectin with anti-wrinkle repair function
[0109] 1. Temperature stability test
[0110] Take 1ml of the purified recombinant fibronectin rFN sample and divide it into 6 EP tubes, place them in water baths at 25°C, 40°C, 50°C, 60°C and 70°C for incubation for 3 hours, centrifuge at 12000rpm for 5min after the water bath is over Afterwards, the supernatants were taken for SDS-PAGE electrophoresis detection.
[0111] The result is as Figure 7A As shown, the first well was incubated at 25°C, and the second, third, fourth, and fifth wells were incubated at 40°C, 50°C, 60°C, and 70°C respectively. M is the pre-stained molecular weight protein marker. The results show: The heat resistance of zonulin rFN is good, no centrifugation precipitation was observed at 25°C for 3 hours, and a small amount of centrifugation precipitation was produced at 40°C, 50°C, 60°C, 70°C for 3 hours, but the remaining recombinant fibronectin in the supernatant The proportion of protein rFN was greater than 80%. Compared with the samples incubated at 40℃, the samples incubated at 70℃ produced more precipitates and the residual recombinant fibronectin rFN in the supernatant was less.
[0112] 2. pH stability test
[0113] Take 10ml of the purified recombinant fibronectin rFN sample and divide it into 11 centrifuge tubes, adjust the pH value of the solution in the centrifuge tubes to 9.0, 8.5, 8.0, 7.5, 7.0, 6.5, 6.0, 5.5, 5.0, 4.5, 12000rpm After centrifugation for 5 min, the supernatant was taken for SDS-PAGE electrophoresis.
[0114] The result is as Figure 7B Shown: Wells 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10 correspond to samples with pH 9.0, 8.5, 8.0, 7.5, 7.0, 6.5, 6.0, 5.5, 5.0, and 4.5, respectively. M is the pre-stained molecular weight protein marker, and the results show that recombinant fibronectin rFN remains stable in an environment with a pH value of 7.5-9.0, and its stability decreases with the decrease of pH value in an environment with a pH value of 5.5-7.0 , in an environment with a pH value of 4.5-5.0, its stability increases as the pH value decreases.
[0115] 3. Salt concentration stability test
[0116] Take 10ml of the purified recombinant fibronectin rFN sample and put it into a centrifuge tube, dialyze it into TBS buffer (20mM Tris, 0-400mM NaCl, pH 8.0) with a salt concentration of 0mM, 100mM, 200mM, 300mM, and 400mM, respectively , dialyzed at 4°C for 48 hours, and changed the medium every 6 hours, then centrifuged at 12,000rpm for 5min and took the supernatant for SDS-PAGE electrophoresis detection.
[0117] The result is as Figure 7C Shown: Wells 1, 2, 3, 4, and 5 correspond to samples in TBS buffer with salt concentrations of 0mM, 100mM, 200mM, 300mM, and 400mM, respectively, and M is the pre-stained molecular weight protein marker. The results show that: recombinant fiber The stability of fibronectin rFN decreased in the buffer system with NaCl concentration of 0mM, and the stability of recombinant fibronectin rFN increased with the increase of NaCl concentration in the buffer system.
[0118] Through this preparation method, the present invention realizes the large-scale preparation of recombinant fibronectin rFN in Escherichia coli, and through the combination of ultra-nickel-resistant metal affinity filler (Smart Ni) and cation exchange filler (CM) purification methods, various fillers obtained High-purity recombinant fibronectin rFN, the N-terminus of recombinant fibronectin rFN has a fragment CnIIIC from the conus peptide, and retains the natural protease cleavage site, and the amino acid residue sequence of the natural fibronectin functional fragment is completely complete Similarly, the fermentation yield of the fusion protein His-SUMO-rFN in the whole preparation process is greater than 8g/L culture medium, the yield of recombinant fibronectin after refining and purification is greater than 50%, and more than 4 grams can be obtained per liter of E. coli fermentation broth with a purity greater than 99% % recombinant fibronectin rFN.
[0119] The advantages of this preparation method are: (1) the His-SUMO tag increases the solubility of recombinant fibronectin rFN and increases the expression level; (2) the high efficiency of the His-tag tagged protein by using the ultra-tolerant nickel affinity filler Recovery (up to more than 90%); (3) ULP1 protease was used for specific cleavage efficiency greater than 99%, which can effectively remove the His-SUMO tag; (4) cationic filler carboxymethyl high flow rate agarose (CM 6FF Beads) can well enrich recombinant fibronectin rFN, improve the purity of recombinant fibronectin rFN (purity greater than 99%), and remove small molecules and endotoxins.
[0120] And the recombinant fibronectin rFN obtained through the above-mentioned purification process contains the CnIIIC functional region from the conus peptide, which can bind and regulate sodium ion channels, and also contains the III domain FnIII-8, FnIII-8, FnIII-9 and FnIII-10 can bind to cell integrin receptors, and retain the natural protease processing site of conopeptide between the two, that is, the GRR sequence at the C-terminus, and the GRR sequence can be specifically recognized by cathepsin And cut, so the two fragments of recombinant fibronectin rFN are derived from natural proteins, do not contain any redundant residues, when used for tissue repair, especially for skin cosmetic purposes, recombinant fibronectin rFN enters the skin tissue, It can be automatically processed by enzymes in skin tissue into CnIIIC and FnIII-8, FnIII-9, FnIII-10. CnIIIC fragments bind to sodium ion channels, regulate nerve current, and have the effect of relaxing wrinkles, analgesia and soothing, FnIII-8, FnIII -9. FnIII-10 can induce the migration and differentiation of fibroblasts, accelerate the repair of damage and reduce the deposition of pigmentation.
[0121] And the recombinant fibronectin rFN prepared by the above-mentioned construction and purification method has a good pH value stability range, an excellent temperature stability range (at 70 ° C for 3 hours, the protein loss is less than 20%), a wide range of salt ion concentration resistance Acceptable range (it is relatively stable in the range of salt concentration of 100mM-400mM).
[0122] Cosmetic formulations usually choose a weakly acidic environment (pH5.0-pH5.5), a salt ion concentration close to physiological conditions (below the ionic strength of normal saline), and a 56-degree heat preservation and sterilization step in production. For the above three points , the recombinant fibronectin rFN prepared by the present invention fully meets the requirements, and therefore is suitable for multiple application fields such as medical treatment and beauty treatment.

PUM

PropertyMeasurementUnit
Molecular weight54.0

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.

Similar technology patents

Preparation method of ferment repair sun cream

InactiveCN106860340Aguard cellsPromotes skin repair
Owner:CHANGSHA XIEHAOJI BIOENG CO LTD

Agalloch eaglewood water and oil mixture and preparation method thereof

InactiveCN111671826AInhibit the growth of bacteria on the wound surfacePromotes skin repair
Owner:中香沉香产业发展(海南自贸区)有限公司

Collagen gel with congelation state

InactiveCN106420392Aanti aginggood skin permeability
Owner:BEIJING PAISHENG BIOTECH CO LTD

Mealworm health-care product improving immunity

InactiveCN105106753Apromote growthanti aging
Owner:重庆涪江生物科技有限公司

Preparation method of ferment repair sun cream

InactiveCN106860353Aguard cellsPromotes skin repair
Owner:CHANGSHA XIEHAOJI BIOENG CO LTD

Classification and recommendation of technical efficacy words

  • Promotes skin repair

Agalloch eaglewood water and oil mixture and preparation method thereof

InactiveCN111671826AInhibit the growth of bacteria on the wound surfacePromotes skin repair
Owner:中香沉香产业发展(海南自贸区)有限公司

Preparation method of ferment repair sun cream

InactiveCN106860353Aguard cellsPromotes skin repair
Owner:CHANGSHA XIEHAOJI BIOENG CO LTD

Preparation method of ferment repair sun cream

InactiveCN106860340Aguard cellsPromotes skin repair
Owner:CHANGSHA XIEHAOJI BIOENG CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products